CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2500
+0.0218 (9.53%)
Oct 19, 2026, 2:10 PM EST
CytoDyn Cash Flow Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Income | -57.1 | -42.7 | 3.75 | -49.84 | -79.82 | -210.82 |
Depreciation & Amortization | 0.03 | 0.02 | 0.02 | 0.03 | 0.18 | 0.78 |
Other Amortization | - | - | 0.41 | 1.65 | 2.2 | 3.05 |
Stock-Based Compensation | 1.98 | 1.63 | 1.61 | 2.42 | 4.28 | 6.24 |
Other Operating Activities | 18.12 | 1.93 | 1.63 | 23.11 | 49.26 | 127.81 |
Change in Inventory | - | - | - | - | - | 2.06 |
Change in Accounts Payable | 13.02 | 17.87 | -11.33 | 10.77 | -3.1 | -2.71 |
Change in Other Net Operating Assets | 1.42 | 4.01 | -4.84 | 0.89 | 1.9 | -4.13 |
Operating Cash Flow | -22.53 | -17.25 | -8.77 | -10.98 | -25.11 | -77.72 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Long-Term Debt Issued | - | - | - | 2.31 | 0.9 | - |
Long-Term Debt Repaid | - | -0.14 | -0.71 | - | - | - |
Total Debt Repaid | - | -0.14 | -0.71 | - | - | - |
Net Debt Issued (Repaid) | - | -0.14 | -0.71 | 2.31 | 0.9 | - |
Issuance of Common Stock | 28.68 | 16.47 | 1.19 | 9.44 | 26.23 | 42.62 |
Other Financing Activities | 0.87 | 0.87 | 10.38 | - | 2.81 | 5.39 |
Financing Cash Flow | 29.56 | 17.2 | 10.85 | 11.75 | 29.93 | 48.01 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Cash Flow | 7.03 | -0.05 | 2.09 | 0.77 | 4.82 | -29.71 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | -22.53 | -17.25 | -8.77 | -10.98 | -25.11 | -77.72 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | - | -29219.17% |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 | -0.12 |
Levered Free Cash Flow | -9.36 | -0.77 | -4.3 | -43.19 | -31.93 | -102.87 |
Unlevered Free Cash Flow | -7.93 | 0.8 | -1.67 | -39.28 | -24.44 | -90.8 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash Interest Paid | 0.01 | 0.02 | 0.03 | 0.05 | 0.02 | 0.06 |
Change in Working Capital | 14.44 | 21.87 | -16.17 | 11.66 | -1.2 | -4.78 |